COURSE DESCRIPTION:
Please join us for a discussion on “The Bloody Truth: Pharmacologic Reversal of Anticoagulant-Associated Life-Threatening Bleed“ with Karen Berger, Pharm.D., FASHP, FCCM, BCPS, BCCCP. Dr. Berger will identify the pharmacologic options for reversal of anticoagulant-associated life-threatening bleeds, compare and contrast the role of concentrated factors versus antidotes, and review the literature supporting the use of reversal agents.
TARGET AUDIENCE:
Internal Medicine Physicians, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, and all other interested healthcare providers
LEARNING OBJECTIVES:
- Identify the pharmacologic options for reversal of anticoagulant-associated life-threatening bleeds.
- Compare and contrast the role of concentrated factors versus antidotes.
- Review the literature supporting the use of reversal agents.
FACULTY AND DISCLOSURES:
Karen Berger, Pharm.D., FASHP, FCCM, BCPS, BCCCP
Neurocritical Care Clinical Pharmacist
Pharmacy Department
Baptist Health Boca Raton Regional Hospital
Boca Raton, Florida
Karen Berger, Pharm. D., FASHP, FCCM, BCPS, BCCCP, faculty for this educational activity, is a consultant for Octapharma and a member of the speakers’ bureau of CSL Behring. She has indicated that the presentation or discussion will include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.
John F. Rubin, M.D., FACP, director of this educational activity, has indicated that he is a shareholder in AstraZeneca and Bristol-Myers Squibb. All of the relevant financial relationships listed for this individual have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Disclosure Policy and Disclaimer
ACCREDITATION STATEMENTS AND CREDITS
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-855841, by the Florida Boards of Medicine, Podiatry, Osteopathic Medicine and Physician Assistants.
This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Florida Board of Athletic Training
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dentistry
- 1.00 Florida Board of Dietitians
- 1.00 Florida Board of Laboratory Personnel
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy